Last reviewed · How we verify
NCT07441811
Urine Albumin/Creatinine Ratio and Renal Function Differences in Phenotypes of Polycystic Ovary Syndrome.
trial in Polycystic Ovary Syndrome in 300 participants. Completed in 20 July 2023.
1 September 2022
Quick facts
| Lead sponsor | Uşak University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 April 2022 |
| Primary completion | 1 September 2022 |
| Estimated completion | 20 July 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →
- Urine Albumin \(UAlb\) — all drugs for Urine Albumin \(UAlb\) →
- Urine Creatinine \(UCr\) — all drugs for Urine Creatinine \(UCr\) →
- Glomerular Filtration Rate — all drugs for Glomerular Filtration Rate →
Sponsor
Uşak University
Who can join
Adults 18 to 35, female only, with Polycystic Ovary Syndrome or Urine Albumin \(UAlb\). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since there are different metabolic effects in different phenotypes of polycystic ovary syndrome (PCOS); in this study; the investigators aimed to investigate whether there is a difference between glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (ACR) levels in different PCOS phenotypes and compare healthy controls.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07441811
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Polycystic Ovary Syndrome
Currently open trials in the same condition.
- NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
- NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
- NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
- NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
- NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting
Other Uşak University trials
Trials by the same sponsor.
- NCT07356362 — High-power Laser Therapy for Notalgia Paresthetica. · NA · not yet recruiting
- NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
- NCT07328360 — The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica · NA · recruiting
- NCT07296380 — Manual Therapy Behavior Scale in Physiotherapists · enrolling by invitation
- NCT07296367 — Physiotherapy and Disaster · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07441811 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uşak University
- Last refreshed: 2 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07441811.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing